Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_4
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Other(2)

Detailed Status

unknown2
Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

unknown240%
completed240%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
recruiting

Nailfold Capillaroscopic Changes in Psoriasis

NCT07693595
completed

Observational Multicenter Case-control Study to Assess Nailfold Capillary Abnormalities in Systemic Lupus Erythematosus

NCT02801812
unknownnot_applicable

Low-field Magnetic Resonance Imaging in Pediatric Post Covid-19

NCT05445531
unknown

NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity

NCT05106998
completedphase_4

Nailfold Capillary Blood Flow With Latanoprost Bunod

NCT03949244

Clinical Trials (5)

Showing 5 of 5 trials
NCT07693595

Nailfold Capillaroscopic Changes in Psoriasis

Recruiting
NCT02801812

Observational Multicenter Case-control Study to Assess Nailfold Capillary Abnormalities in Systemic Lupus Erythematosus

Completed
NCT05445531Not Applicable

Low-field Magnetic Resonance Imaging in Pediatric Post Covid-19

Unknown
NCT05106998

NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity

Unknown
NCT03949244Phase 4

Nailfold Capillary Blood Flow With Latanoprost Bunod

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5